These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18424786)

  • 1. Diabetes, left ventricular systolic dysfunction, and chronic heart failure.
    MacDonald MR; Petrie MC; Hawkins NM; Petrie JR; Fisher M; McKelvie R; Aguilar D; Krum H; McMurray JJ
    Eur Heart J; 2008 May; 29(10):1224-40. PubMed ID: 18424786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and prognosis: are systolic and diastolic heart failure different?
    Kamalesh M
    Heart; 2009 Mar; 95(3):178-9. PubMed ID: 19033294
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of heart failure in patients with diabetes: clinical update.
    Bell DS
    Ethn Dis; 2002; 12(1):S1-12-8. PubMed ID: 11915848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH; Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and cardiac failure in its various forms.
    Gaddam KK; Verma A; Thompson M; Amin R; Ventura H
    Med Clin North Am; 2009 May; 93(3):665-80. PubMed ID: 19427498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of heart failure.
    Quinn B
    Crit Care Nurs Q; 2007; 30(4):299-306. PubMed ID: 17873566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
    Stratmann B; Tschoepe D
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.
    Masoudi FA; Inzucchi SE
    Am J Cardiol; 2007 Feb; 99(4A):113B-132B. PubMed ID: 17307064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF; Thygesen K; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L; Cleland JG
    J Card Fail; 2008 Oct; 14(8):670-5. PubMed ID: 18926439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure and diabetes mellitus: epidemiology and management of an alarming association.
    Cohen-Solal A; Beauvais F; Logeart D
    J Card Fail; 2008 Sep; 14(7):615-25. PubMed ID: 18722328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].
    Zoghi M; Duygu H; Güngör H; Nalbantgil S; Yilmaz GM; Tülüce K; Ozerkan F; Akilli A; Akin M
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):255-9. PubMed ID: 18676300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure in the diabetic patient.
    Bell DS
    Cardiol Clin; 2007 Nov; 25(4):523-38; vi. PubMed ID: 18063157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in diastolic heart failure: an update.
    Fitzgibbons TP; Meyer TE; Aurigemma GP
    Cardiol Rev; 2009; 17(2):51-5. PubMed ID: 19367145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to chronic systolic heart failure, guideline-directed medical therapy, and systemic hypotension-less pressure but maybe more risk (does this clinical scenario need more discussion?).
    Satya K; Alhaj E; Berkowtiz RL
    J Card Fail; 2009 Jun; 15(5):465. PubMed ID: 19477409
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological treatment of chronic systolic heart failure: are we scraping the bottom of the barrel?
    Abate E; Sartor R; Ceconi C; Boffa GM
    J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):893-905. PubMed ID: 20414119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.